Skip to main content
Tsiporah Shore, MD, Oncology, New York, NY, New York-Presbyterian Hospital

TsiporahBShoreMD

Oncology • New York, NY

Hematologic Oncology

Professor, Medicine, Weill Cornell Medical College

Request Appointment

Overview of Dr. Shore

Dr. Tsiporah Shore is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including NewYork-Presbyterian/Weill Cornell and New York-Presbyterian Hospital. She received her medical degree from University of Manitoba and has been in practice 38 years. She specializes in hematologic oncology and is experienced in hematologic oncology, and bone marrow/ stem cell transplantation.

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1985
  • University of Manitoba
    University of ManitobaClass of 1979

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1999 - 2025
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • Royal College of Physicians and Surgeons of CanadaHematology
  • Royal College of Physicians and Surgeons of CanadaInternal Medicine

Awards, Honors, & Recognition

  • Certificate of Excellence in Reviewing Leukemia Research, 2013
  • Fellow American College of Physicians, 1999
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Incidence, Significance, and Persistence of Human Coronavirus Infection in Hematopoietic Stem Cell Transplant Recipients  
    Catherine B Small, Rosemary Soave, Dana Zappetti, Michael J Satlin, Emily M Eichenberger, Tsiporah Shore, Nature

Abstracts/Posters

  • Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34+ pr...
    Tsiporah B. Shore, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration
    Tsiporah B. Shore, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/7/2019
  • Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T Infusion
    Tsiporah B. Shore, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant? 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    Anthem Blue Access PPO
    Anthem Blue Preferred HMO
    BCBS Blue Card PPO
    BCBS Idaho PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Cofinity PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    MagnaCare PPO
    Medical Mutual of Ohio SuperMed POS
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    ODS Network
    Oxford Health Freedom
    Oxford Health Liberty
    PacificSource Preferred PSN
    Sagamore Health Plus
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Tsiporah Shore, Dr. Tsiporah Shore, MD, Dr. T Shore, Dr. Tsiporah B Shore